Macrophages infiltrating the treated myocardium bind anti-Gal coated α-gal nanoparticles via Fc/Fc receptor interaction (Stage 2 in Figure 1), as shown in Figures 2C,D, whereas these nanoparticles are absent in the control post-MI myocardium. The gene discussed is GAL; the disease is myocardial infarction.